Gastroenterology
Conference Coverage
PET-directed induction therapy improves esophageal cancer outcomes
The use of positron emission tomography to assess esophageal tumor response to induction chemotherapy and to guide a regimen change in those who...
From the Journals
Esophageal cancers: Apples and oranges wrongly lumped together
Genomic analysis suggests esophageal adenocarcinoma and esophageal squamous cell carcinoma are two separate diseases that should not be combined...
From the Journals
177Lu-Dotatate for advanced midgut neuroendocrine tumors
177Lu-Dotatate, a radionuclide related to octreotide, reduced the risk of disease progression or death by 79% in a phase III trial involving 229...
From the Journals
Sorafenib survival benefit in HCC depends on etiology
The impact of sorafenib in treating patients with advanced hepatocellular cancer may be dependent on their hepatitis status, according to a meta-...
From the Journals
Gastric cancer yields to growth hormone antagonist in lab
It sounds counterintuitive, but targeting a neuropeptide hormone produced in the hypothalamus may be an effective strategy for treating gastric...
New Therapies
Pancreatic cancer: a therapeutic challenge yet to be met
Original Report
Patients’ retrospective assessment of palliative chemotherapy for lung or gastrointestinal cancers
From the Journals
Mutations missed in early-onset colorectal cancer
As many as one in six patients with early-onset colorectal cancer have a pathogenic genetic mutation, but around one-third of these patients may...
From the Journals
KRAS-targeted T-cell therapy derails metastatic cancer
Adoptive transfer of cytotoxic T cells targeting a specific KRAS mutation (KRAS G12D) expressed by a metastatic colorectal cancer induced the...
From the Journals
Genetics dictate interferon-alfa diarrhea risk
Interferon-alfa impairs human intestinal mucosa homeostasis by eliciting epithelial barrier disruption via apoptosis, and the intestinal mucosa...
From the Journals
VIDEO: Y90 radioembolization beat chemoembolization in liver cancer
Liver cancer took nearly four times longer to progress after yttrium-90 radioembolization than after conventional transarterial chemoembolization...